Shares of Pfizer declined nearly 3 percent in Wednesday’s trade on valuation concerns, even as the drug maker’s fundamentals remain strong. The stock has climbed 37 percent in last three months and 74 percent on a year-to-date basis.
For more information on stock tips
and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co
Connect with our social media sites
Follow @Epic_Research
and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co
Connect with our social media sites
Follow @Epic_Research
0 comments:
Post a Comment